Lurasidone in Children and Adolescents with Bipolar Depression Presenting with Mixed (Subsyndromal Hypomanic) Features: Post Hoc Analysis of a Randomized Placebo-Controlled Trial

Objectives: To evaluate the efficacy and safety of lurasidone in the treatment of children and adolescents with bipolar depression presenting with mixed (subsyndromal hypomanic) features. Methods: Patients, 10–17 years of age, with a Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (DS...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Manpreet K., Pikalov, Andrei, Siu, Cynthia, Tocco, Michael, Loebel, Antony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757594/
https://www.ncbi.nlm.nih.gov/pubmed/32392455
http://dx.doi.org/10.1089/cap.2020.0018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757594/
https://www.ncbi.nlm.nih.gov/pubmed/32392455
http://dx.doi.org/10.1089/cap.2020.0018

Ejemplares similares